• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Collagen alpha-3 (IX) chain (COL9A3)

ACP18376

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18376 Target NameCOL9A3
Target SynonymsCOL9A3Collagen alpha-3(IX) chainFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range26-684
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14050
Background Information
  • Uniprot Id

    Q14050

  • Target Species

    Human

  • Target Name

    COL9A3

  • Target Full Name

    Collagen alpha-3(IX) chain

  • Target Function

    Structural component of hyaline cartilage and vitreous of the eye.

  • Target Involvement

    Multiple epiphyseal dysplasia 3 (EDM3); Intervertebral disc disease (IDD)

  • Target Subcellular Location

    Secreted, extracellular space, extracellular matrix.

  • Target Protein Families

    Fibril-associated collagens with interrupted helices (FACIT) family

  • Target Synonyms

    COL9A3Collagen alpha-3(IX) chain

  • Target Background

    This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.

Inquire Recombinant Human Collagen alpha-3 (IX) chain (COL9A3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification